NTRB Projected Dividend Yield
Nutriband Inc ( NASDAQ : NTRB )Nutriband is engaged in the development of a portfolio of transdermal pharmaceutical products. Co.'s key product is its abuse deterrent fentanyl transdermal system which it is developing to provide clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy combined with properties designed to help combat the opioid crisis by deterring the abuse and misuse of fentanyl patches. Co. is developing a portfolio of transdermal pharmaceutical products to deliver commercially available drugs or biologics that are delivered by injection but with the potential to improve compliance and therapeutic outcomes. 20 YEAR PERFORMANCE RESULTS |
NTRB Dividend History Detail NTRB Dividend News NTRB Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |